Results 261 to 270 of about 340,012 (316)

Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma. [PDF]

Cancer Commun (Lond)
Mariniello K, Pittaway JFH, Altieri B, Borges KS, Hadjidemetriou I, Ribeiro C, Ruiz-Babot G, Tourigny DS, Lim JA, Foster J, Cleaver J, Sosabowski J, Rahman N, Doroszko M, Hantel C, Sigala S, Abate A, Tamburello M, Kiseljak-Vassiliades K, Wierman M, Hall C, Parvanta L, Abdel-Aziz TE, Chung TT, Marco AD, Palazzo F, Gomez-Sanchez CE, Taylor DR, Rayner O, Ronchi CL, Gaston-Massuet C, Sbiera S, Drake WM, Rognoni E, Kroiss M, Breault DT, Fassnacht M, Guasti L.   +37 more
europepmc   +1 more source

Organoid modeling reveals the tumorigenic potential of the alveolar progenitor cell state. [PDF]

EMBO J
Li J, Dang SM, Sengupta S, Schurmann P, Dost AFM, Moye AL, Trovero MF, Ahmed S, Paschini M, Bhetariya PJ, Bronson R, Ho Sui SJ, Kim CF.   +12 more
europepmc   +1 more source

Correction to "Bone Marrow Endothelial Progenitor Cell Transplantation After Ischemic Stroke: An Investigation Into Its Possible Mechanism". [PDF]

CNS Neurosci Ther
europepmc   +1 more source

Endothelial Progenitor Cells [PDF]

New England Journal of Medicine, 2003
Vascular endothelial cells form a lining — one cell thick — for all the blood vessels in the body, providing a critical interface between the vessel itself and blood-borne elements.
Jeffrey M. Isner, Takayuki Asahara
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Endothelial Progenitor Cells

Annual Review of Medicine, 2005
Endothelial progenitor cells are a circulating, bone marrow–derived cell population that appears to participate in both vasculogenesis and vascular homeostasis. Questions persist regarding their functional characteristics, as well as the precise panel of cell surface markers that uniquely define this newly described progenitor cell population.
Aarif Y. Khakoo, Toren Finkel
openaire   +3 more sources

Cardiac Progenitor Cells

2020
Cardiovascular diseases top the list of fatal illnesses worldwide. Cardiac tissues is known to be one of te least proliferative in the human body, with very limited regenraive capacity. Stem cell therapy has shown great potential for treatment of cardiovascular diseases in the experimental setting, but success in human trials has been limited ...
Haya Mohamed, Sara S. Elshaboury, Amr Zaher, Bahaa Eldin Fouda, Samar Sakr, Nagwa El-Badri, Shaimaa Shouman, Alaa Abdelhameed   +7 more
openaire   +3 more sources

Hepatic progenitor cells

Cell and Tissue Research, 2010
Liver diseases are associated with a marked reduction in the viable mass of hepatocytes. The most severe cases of liver disease (liver failure) are treated by orthotopic liver transplantation. One alternative to whole organ transplantation for patients with hepatic failure (and hereditary liver disease) is hepatocyte transplantation.
Caroline Beth Sangan, David Tosh
openaire   +3 more sources

Endothelial Progenitor Cells

Endothelium, 2006
The identification of circulating endothelial progenitor cells (EPCs) has prompted an explosion of interest in postnatal vasculogenesis and the role of this mechanism in human health and disease. Previously considered restricted to the embryonic phase, the differentiation in situ of progenitor cells to vascular endothelium is now known to occur in the ...
Noel M. Caplice, Pat Metharom, Brendan Doyle   +2 more
openaire   +3 more sources

Endothelial Progenitor Cells in Prehypertension

Current Pharmaceutical Design, 2011
Blood pressure within prehypertensive levels confers higher cardiovascular risk. As prehypertension is also an intermediate stage for full hypertension, a precocious intervention with lifestyle changes or drugs is therefore appealing. Endothelial injury and dysfunction are thought to contribute to cardiovascular risk in prehypertension.
DI STEFANO, ROSSELLA, Barsotti MC, FELICE, FRANCESCA, Vlachopoulos C, BALBARINI, ALBERTO   +4 more
openaire   +4 more sources